Clinical Trials for Metastatic Colorectal Adenocarcinoma

Find clinical trials for metastatic colorectal adenocarcinoma. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

NCT ID: NCT06102902

This clinical trial is studying a new treatment approach for patients with advanced colorectal cancer that has not responded to previous therapies. The trial combines a new drug called ZEN003694 wi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Oklahoma City, Oklahoma, United States, Charlottesville, Virginia, United States +11 more

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

NCT ID: NCT06696768

This clinical trial is looking at a new anti-cancer drug called CA-4948 (also known as Emavusertib) combined with a standard chemotherapy treatment called FOLFOX (which includes the drugs fluoroura...

Recruiting

Phase: PHASE1 Type: interventional Locations: Oklahoma City, Oklahoma, United States, New Haven, Connecticut, United States

Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients with KRAS-Mutant Metastatic Colorectal Cancer

NCT ID: NCT06336902

This clinical trial is testing a new treatment approach for patients with a type of advanced colorectal cancer that has a specific mutation called KRAS. The study is looking at a combination of two...

Recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States, Los Angeles, California, United States

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, the ERASur Study

NCT ID: NCT05673148

The ERASur Study is a clinical trial designed to find out if adding a specific type of treatment called total ablative therapy can improve outcomes for patients with a type of colorectal cancer tha...

Recruiting

Phase: PHASE3 Type: interventional Locations: Milwaukee, Wisconsin, United States, Flint, Michigan, United States +153 more

Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer

NCT ID: NCT02600949

This clinical trial is testing a new treatment called a personalized peptide vaccine for patients with advanced pancreatic or colorectal cancer that has spread to other parts of the body. The vacci...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

NCT ID: NCT04511039

This clinical trial is studying the combination of two cancer treatments, trifluridine/tipiracil and talazoparib, to see how well they work together for patients with advanced colorectal or gastroe...

Recruiting

Phase: PHASE1 Type: interventional Locations: Buffalo, New York, United States

Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC

NCT ID: NCT06195670

This clinical trial is exploring a new treatment approach for patients with advanced metastatic colorectal cancer (mCRC) who are not able to undergo more aggressive therapies. Specifically, the stu...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Hangzhou, Zhejiang, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions